Concepedia

Yosuke Harazono

YH

Statistics

Publications

11

Citations

613

H-Index

11

Active since

2013

Affiliations

Tokyo Medical and Dental University(Current)

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Abcombi Biosciences (United States)

Fundação de Amparo à Pesquisa do Estado de São Paulo

Yosuke Harazono is an author at Tokyo Medical and Dental University specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2013–2023

11

Publications

11

miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2

Yosuke Harazono, Tomoki Muramatsu, Hironori Endo et al. · PLoS ONE · 2013 · 115 citations · Full text

, , +17

Ripening-induced chemical modifications of papaya pectin inhibit cancer cell proliferation

Samira Bernardino Ramos do Prado, Gabrielle Fernandez Ferreira, Yosuke Harazono et al. · Scientific Reports · 2017 · 85 citations · Full text

, , +17

Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling

Kosei Nakajima, Dhong Hyo Kho, Takashi Yanagawa et al. · Neoplasia · 2014 · 84 citations · Full text

, , +17

Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells

Yosuke Harazono, Dhong Hyo Kho, Vitaly Balan et al. · Oncotarget · 2014 · 64 citations · Full text

, , +16

Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis

Kosei Nakajima, Dhong Hyo Kho, Takashi Yanagawa et al. · Cancer Research · 2016 · 63 citations · Full text

, , +17

1–5 of 11